Trial showed promising results for patients with IBD and autoimmune liver disease with 80% achieving clinical remission ...
Pliant Therapeutics, Inc. (NASDAQ:PLRX) stock is trading lower on Monday. On Friday, during after-hours trading, Pliant ...